Status:
NOT_YET_RECRUITING
Repetitive Transcranial Magnetic Stimulation in Cancer Pain Management
Lead Sponsor:
Taipei Medical University Hospital
Conditions:
Pain
Cancer
Eligibility:
All Genders
20-70 years
Phase:
NA
Brief Summary
Over half of cancer patients experience cancer-related pain. Despite advances in pain management with opioids, many patients continue to suffer from chronic cancer pain. The underlying mechanisms of c...
Eligibility Criteria
Inclusion
- Patients have cancer pain symptoms, confirmed by a physician as cancer pain or neuropathic cancer pain
- Experienced the worst pain NRS score ≥ 4
- The patient demonstrate good cognition and is able to cooperate with the assessment of pain severity.
- The estimated survival time exceeds 3 months.
- Pre-existing bisphosphonate, chemotherapy, and hormonal therapy regimens remained unchanged throughout the study.
Exclusion
- Individuals who have undergone head surgery or have metal implants in the head.
- Individuals with implanted cardiac pacemakers or cochlear prostheses.
- Have a history of epilepsy.
- Patients diagnosed with primary brain tumors or metastatic brain lesions.
- Present with additional neurological, psychiatric, or severe medical disorders.
- Individuals with metallic implants located in the cranial or cervical regions.
- Women who are pregnant.
- Presence of acute pain in any body region attributable to other medical conditions. -
Key Trial Info
Start Date :
May 20 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06949618
Start Date
May 20 2025
End Date
December 30 2026
Last Update
May 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei Medical University Hospital
Taipei, Taiwan, Taiwan, 110